 Jerry Stitzel
Concepts (382)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 67 | 2025 | 334 | 9.210 |
Why?
| | Nicotine | 46 | 2025 | 334 | 7.510 |
Why?
| | Nicotinic Agonists | 18 | 2025 | 129 | 3.010 |
Why?
| | Tobacco Use Disorder | 19 | 2025 | 251 | 2.650 |
Why?
| | Prenatal Exposure Delayed Effects | 5 | 2021 | 605 | 1.420 |
Why?
| | Polymorphism, Single Nucleotide | 22 | 2023 | 2189 | 1.210 |
Why?
| | Smoking | 15 | 2023 | 1627 | 1.190 |
Why?
| | Brain | 22 | 2020 | 2668 | 1.190 |
Why?
| | Neurodevelopmental Disorders | 2 | 2021 | 181 | 1.180 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 12 | 2017 | 97 | 1.040 |
Why?
| | Polymorphism, Genetic | 12 | 2014 | 660 | 1.020 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 660 | 0.980 |
Why?
| | Mice | 60 | 2025 | 17787 | 0.970 |
Why?
| | Mice, Inbred C3H | 15 | 2015 | 269 | 0.880 |
Why?
| | Hippocampus | 10 | 2019 | 895 | 0.850 |
Why?
| | Bungarotoxins | 19 | 2014 | 46 | 0.840 |
Why?
| | Protein Subunits | 8 | 2017 | 239 | 0.790 |
Why?
| | Melatonin | 2 | 2015 | 150 | 0.780 |
Why?
| | Substance Withdrawal Syndrome | 4 | 2025 | 179 | 0.760 |
Why?
| | Animals | 66 | 2025 | 36940 | 0.760 |
Why?
| | Nerve Tissue Proteins | 9 | 2018 | 596 | 0.700 |
Why?
| | Mice, Inbred C57BL | 22 | 2025 | 5757 | 0.670 |
Why?
| | Sleep | 5 | 2025 | 755 | 0.660 |
Why?
| | Synaptosomes | 6 | 2014 | 30 | 0.650 |
Why?
| | Mice, Inbred DBA | 17 | 2015 | 200 | 0.650 |
Why?
| | Neurons | 4 | 2018 | 1590 | 0.630 |
Why?
| | Frontal Lobe | 2 | 2019 | 149 | 0.610 |
Why?
| | Nicotinic Antagonists | 7 | 2017 | 34 | 0.600 |
Why?
| | Genetic Variation | 9 | 2022 | 991 | 0.600 |
Why?
| | Protein Precursors | 1 | 2019 | 134 | 0.600 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2019 | 131 | 0.590 |
Why?
| | DNA Methylation | 2 | 2021 | 643 | 0.580 |
Why?
| | Choice Behavior | 5 | 2015 | 170 | 0.570 |
Why?
| | Serine | 1 | 2018 | 141 | 0.570 |
Why?
| | Wakefulness | 1 | 2018 | 125 | 0.560 |
Why?
| | Gene Expression Regulation | 7 | 2013 | 2607 | 0.550 |
Why?
| | Protein Processing, Post-Translational | 1 | 2020 | 465 | 0.540 |
Why?
| | Species Specificity | 14 | 2012 | 585 | 0.520 |
Why?
| | Motor Activity | 12 | 2022 | 718 | 0.500 |
Why?
| | Ethanol | 6 | 2022 | 608 | 0.470 |
Why?
| | Receptors, Melatonin | 1 | 2015 | 2 | 0.470 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 286 | 0.470 |
Why?
| | Glucocorticoids | 1 | 2019 | 594 | 0.460 |
Why?
| | Gene Expression | 7 | 2015 | 1502 | 0.450 |
Why?
| | GABA-B Receptor Agonists | 1 | 2014 | 6 | 0.450 |
Why?
| | Receptors, GABA-B | 1 | 2014 | 11 | 0.450 |
Why?
| | Sensory Gating | 1 | 2015 | 45 | 0.450 |
Why?
| | Baclofen | 1 | 2014 | 19 | 0.440 |
Why?
| | Drinking | 3 | 2015 | 42 | 0.430 |
Why?
| | Polymorphism, Restriction Fragment Length | 7 | 2007 | 68 | 0.420 |
Why?
| | Behavior, Animal | 7 | 2019 | 501 | 0.410 |
Why?
| | Alcohol Drinking | 5 | 2022 | 828 | 0.410 |
Why?
| | Schizophrenia | 4 | 2017 | 439 | 0.400 |
Why?
| | Acetylcholine | 7 | 2012 | 185 | 0.400 |
Why?
| | Male | 54 | 2025 | 67762 | 0.380 |
Why?
| | Circadian Rhythm | 2 | 2015 | 468 | 0.370 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 5 | 2018 | 227 | 0.370 |
Why?
| | Gene Targeting | 2 | 2011 | 81 | 0.370 |
Why?
| | Mice, Knockout | 11 | 2025 | 3015 | 0.360 |
Why?
| | Mice, Inbred Strains | 10 | 2005 | 409 | 0.360 |
Why?
| | Pregnancy | 7 | 2021 | 6763 | 0.360 |
Why?
| | Calcium | 3 | 2015 | 1199 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2012 | 2057 | 0.350 |
Why?
| | Female | 52 | 2025 | 73304 | 0.350 |
Why?
| | Drug Discovery | 1 | 2011 | 142 | 0.330 |
Why?
| | Administration, Oral | 4 | 2018 | 816 | 0.330 |
Why?
| | Pyridines | 5 | 2018 | 506 | 0.330 |
Why?
| | Gene Knock-In Techniques | 1 | 2010 | 56 | 0.320 |
Why?
| | Seizures | 4 | 2007 | 426 | 0.320 |
Why?
| | Rubidium | 4 | 2002 | 12 | 0.310 |
Why?
| | Phenotype | 12 | 2023 | 3196 | 0.300 |
Why?
| | Oocytes | 1 | 2010 | 181 | 0.300 |
Why?
| | Disease Models, Animal | 10 | 2023 | 4295 | 0.300 |
Why?
| | Chromosome Mapping | 2 | 2006 | 523 | 0.290 |
Why?
| | Taste | 2 | 2015 | 229 | 0.290 |
Why?
| | Genetic Predisposition to Disease | 8 | 2022 | 2426 | 0.290 |
Why?
| | Promoter Regions, Genetic | 4 | 2015 | 1250 | 0.290 |
Why?
| | Signal Transduction | 3 | 2019 | 5079 | 0.290 |
Why?
| | Brain Chemistry | 2 | 2007 | 117 | 0.280 |
Why?
| | Chlorisondamine | 1 | 2007 | 3 | 0.280 |
Why?
| | Central Nervous System Depressants | 3 | 2005 | 85 | 0.280 |
Why?
| | Genes, fos | 1 | 2007 | 36 | 0.280 |
Why?
| | Aging | 2 | 2022 | 1864 | 0.270 |
Why?
| | Neural Inhibition | 4 | 2017 | 169 | 0.260 |
Why?
| | Corticosterone | 2 | 2019 | 236 | 0.260 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2167 | 0.260 |
Why?
| | Genotype | 14 | 2014 | 1916 | 0.250 |
Why?
| | Microsatellite Repeats | 1 | 2006 | 168 | 0.240 |
Why?
| | Quantitative Trait Loci | 2 | 2015 | 380 | 0.240 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 14 | 0.230 |
Why?
| | Genome-Wide Association Study | 6 | 2023 | 1431 | 0.230 |
Why?
| | Corpus Striatum | 5 | 2019 | 167 | 0.230 |
Why?
| | Anxiety | 1 | 2012 | 1035 | 0.230 |
Why?
| | Multifactorial Inheritance | 2 | 2023 | 174 | 0.220 |
Why?
| | Up-Regulation | 2 | 2018 | 843 | 0.220 |
Why?
| | DNA-Binding Proteins | 2 | 2022 | 1502 | 0.210 |
Why?
| | Choline | 2 | 2015 | 127 | 0.210 |
Why?
| | Astrocytes | 1 | 2025 | 210 | 0.200 |
Why?
| | Maze Learning | 3 | 2012 | 103 | 0.200 |
Why?
| | Epistasis, Genetic | 1 | 2023 | 70 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2025 | 437 | 0.200 |
Why?
| | Chronobiology Disorders | 1 | 2022 | 13 | 0.190 |
Why?
| | Genetic Markers | 2 | 2020 | 344 | 0.190 |
Why?
| | Tobacco Use | 1 | 2022 | 64 | 0.190 |
Why?
| | Internationality | 1 | 2022 | 155 | 0.190 |
Why?
| | Quinolizines | 3 | 2010 | 9 | 0.180 |
Why?
| | Azocines | 3 | 2010 | 8 | 0.180 |
Why?
| | Maternal Inheritance | 1 | 2021 | 16 | 0.180 |
Why?
| | Alkaloids | 3 | 2010 | 30 | 0.180 |
Why?
| | Alternative Splicing | 1 | 2003 | 229 | 0.180 |
Why?
| | Benzazepines | 2 | 2012 | 39 | 0.180 |
Why?
| | Humans | 39 | 2024 | 137585 | 0.180 |
Why?
| | Varenicline | 2 | 2012 | 25 | 0.180 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2014 | 198 | 0.170 |
Why?
| | Electroencephalography | 2 | 2025 | 423 | 0.170 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 218 | 0.170 |
Why?
| | Quinoxalines | 2 | 2012 | 66 | 0.170 |
Why?
| | Alzheimer Disease | 2 | 2022 | 560 | 0.170 |
Why?
| | Muscle Proteins | 1 | 2022 | 231 | 0.170 |
Why?
| | Radioligand Assay | 3 | 2012 | 48 | 0.170 |
Why?
| | Histone Deacetylase 2 | 1 | 2020 | 10 | 0.170 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 32 | 0.160 |
Why?
| | Dioxygenases | 1 | 2020 | 26 | 0.160 |
Why?
| | Dopamine | 3 | 2019 | 303 | 0.160 |
Why?
| | Transcriptome | 2 | 2023 | 971 | 0.160 |
Why?
| | Methyl-CpG-Binding Protein 2 | 1 | 2020 | 21 | 0.160 |
Why?
| | Amino Acid Substitution | 3 | 2009 | 307 | 0.160 |
Why?
| | Cell Line | 6 | 2017 | 2847 | 0.160 |
Why?
| | Muscle, Skeletal | 1 | 2010 | 1724 | 0.160 |
Why?
| | Furin | 1 | 2019 | 14 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 2020 | 81 | 0.160 |
Why?
| | Self Administration | 3 | 2025 | 123 | 0.160 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2019 | 27 | 0.160 |
Why?
| | Aequorin | 2 | 2012 | 2 | 0.160 |
Why?
| | Sexual Maturation | 1 | 2019 | 55 | 0.160 |
Why?
| | Body Temperature | 8 | 2015 | 222 | 0.150 |
Why?
| | Visual Cortex | 1 | 2019 | 70 | 0.150 |
Why?
| | Sleep, REM | 1 | 2018 | 33 | 0.150 |
Why?
| | Gene-Environment Interaction | 2 | 2018 | 192 | 0.150 |
Why?
| | Sex Factors | 3 | 2012 | 2071 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2018 | 375 | 0.140 |
Why?
| | Sex Characteristics | 4 | 2025 | 762 | 0.140 |
Why?
| | Autoradiography | 3 | 2009 | 78 | 0.130 |
Why?
| | Myocarditis | 1 | 2018 | 100 | 0.130 |
Why?
| | Cytochrome P-450 CYP2A6 | 1 | 2016 | 11 | 0.130 |
Why?
| | Acoustic Stimulation | 3 | 2015 | 312 | 0.130 |
Why?
| | Mutation | 4 | 2022 | 3958 | 0.130 |
Why?
| | Pyramidal Cells | 1 | 2017 | 74 | 0.130 |
Why?
| | Proto-Oncogene Proteins | 1 | 2020 | 648 | 0.130 |
Why?
| | Genetic Linkage | 1 | 1996 | 297 | 0.120 |
Why?
| | HEK293 Cells | 3 | 2015 | 730 | 0.120 |
Why?
| | Alleles | 4 | 2013 | 891 | 0.120 |
Why?
| | Substance-Related Disorders | 1 | 2005 | 1083 | 0.120 |
Why?
| | Time Factors | 6 | 2018 | 6828 | 0.120 |
Why?
| | Cerebral Cortex | 3 | 2009 | 433 | 0.120 |
Why?
| | Down Syndrome | 1 | 2022 | 496 | 0.120 |
Why?
| | Receptor, Melatonin, MT1 | 1 | 2015 | 6 | 0.120 |
Why?
| | Cigarette Smoking | 1 | 2016 | 101 | 0.120 |
Why?
| | Analysis of Variance | 2 | 2012 | 1316 | 0.120 |
Why?
| | Mesencephalon | 1 | 2015 | 66 | 0.120 |
Why?
| | Isoxazoles | 1 | 2015 | 54 | 0.110 |
Why?
| | Autoreceptors | 1 | 2014 | 4 | 0.110 |
Why?
| | Pyrethrins | 1 | 2014 | 8 | 0.110 |
Why?
| | Conotoxins | 2 | 2004 | 14 | 0.110 |
Why?
| | Potassium Chloride | 1 | 2014 | 38 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2019 | 860 | 0.110 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 97 | 0.110 |
Why?
| | Social Behavior | 1 | 2017 | 287 | 0.110 |
Why?
| | Macrophages, Alveolar | 1 | 2017 | 391 | 0.110 |
Why?
| | Calcineurin Inhibitors | 1 | 2014 | 72 | 0.110 |
Why?
| | Heterozygote | 1 | 2015 | 293 | 0.110 |
Why?
| | Mycobacterium tuberculosis | 1 | 2017 | 314 | 0.110 |
Why?
| | Neurogenesis | 1 | 2015 | 149 | 0.110 |
Why?
| | Auditory Perception | 1 | 2015 | 112 | 0.110 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 301 | 0.110 |
Why?
| | Crosses, Genetic | 2 | 2006 | 137 | 0.110 |
Why?
| | Base Sequence | 4 | 2013 | 2181 | 0.100 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 55 | 0.100 |
Why?
| | Presynaptic Terminals | 1 | 2014 | 88 | 0.100 |
Why?
| | DNA, Intergenic | 1 | 2013 | 26 | 0.100 |
Why?
| | Haplotypes | 4 | 2018 | 494 | 0.100 |
Why?
| | In Situ Hybridization | 3 | 2003 | 316 | 0.100 |
Why?
| | Patch-Clamp Techniques | 2 | 2004 | 286 | 0.100 |
Why?
| | Protein Kinase C | 1 | 2014 | 261 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 976 | 0.100 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 145 | 0.100 |
Why?
| | Permeability | 1 | 2012 | 161 | 0.090 |
Why?
| | Dihydro-beta-Erythroidine | 2 | 2010 | 6 | 0.090 |
Why?
| | In Vitro Techniques | 3 | 2003 | 1092 | 0.090 |
Why?
| | Rubidium Radioisotopes | 4 | 2004 | 8 | 0.090 |
Why?
| | Statistics as Topic | 1 | 2012 | 307 | 0.090 |
Why?
| | Transfection | 3 | 2013 | 945 | 0.090 |
Why?
| | Alcoholism | 3 | 2008 | 807 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2018 | 1046 | 0.090 |
Why?
| | Food Preferences | 1 | 2012 | 119 | 0.090 |
Why?
| | Gene Frequency | 2 | 2009 | 521 | 0.090 |
Why?
| | Iodine Radioisotopes | 2 | 2009 | 145 | 0.080 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 363 | 0.080 |
Why?
| | Decamethonium Compounds | 1 | 2010 | 1 | 0.080 |
Why?
| | Hexamethonium | 1 | 2010 | 4 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2139 | 0.080 |
Why?
| | Mecamylamine | 1 | 2010 | 9 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 852 | 0.080 |
Why?
| | Xenopus laevis | 1 | 2010 | 106 | 0.080 |
Why?
| | Animals, Newborn | 1 | 2012 | 844 | 0.080 |
Why?
| | Electrophysiology | 1 | 2010 | 217 | 0.080 |
Why?
| | Genetic Association Studies | 3 | 2018 | 377 | 0.080 |
Why?
| | Organ Specificity | 1 | 2010 | 305 | 0.080 |
Why?
| | Dithiothreitol | 2 | 1988 | 17 | 0.080 |
Why?
| | Rats | 5 | 2013 | 5647 | 0.070 |
Why?
| | Risk | 3 | 2019 | 912 | 0.070 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2008 | 45 | 0.070 |
Why?
| | Luciferases | 3 | 2013 | 150 | 0.070 |
Why?
| | Columbidae | 1 | 2007 | 31 | 0.070 |
Why?
| | Epilepsy | 2 | 2012 | 333 | 0.070 |
Why?
| | Europe | 2 | 2022 | 414 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2025 | 4193 | 0.070 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 113 | 0.070 |
Why?
| | Mice, Congenic | 1 | 2006 | 22 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2015 | 2833 | 0.070 |
Why?
| | Lod Score | 1 | 2006 | 67 | 0.070 |
Why?
| | Drug Interactions | 2 | 2004 | 410 | 0.060 |
Why?
| | RNA | 2 | 2010 | 921 | 0.060 |
Why?
| | Drinking Behavior | 1 | 2005 | 10 | 0.060 |
Why?
| | Reflex, Startle | 5 | 2017 | 65 | 0.060 |
Why?
| | Age of Onset | 2 | 2020 | 518 | 0.060 |
Why?
| | Cadmium Chloride | 1 | 2004 | 4 | 0.060 |
Why?
| | Macrocyclic Compounds | 1 | 2004 | 9 | 0.060 |
Why?
| | Thalamus | 2 | 2009 | 107 | 0.060 |
Why?
| | Ryanodine | 1 | 2004 | 15 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 100 | 0.060 |
Why?
| | Oxazoles | 1 | 2004 | 37 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 90 | 0.060 |
Why?
| | Snails | 1 | 2004 | 37 | 0.060 |
Why?
| | Algorithms | 1 | 2012 | 1704 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 3295 | 0.060 |
Why?
| | Binding, Competitive | 3 | 2003 | 202 | 0.060 |
Why?
| | Adult | 12 | 2016 | 37929 | 0.060 |
Why?
| | Extracellular Space | 1 | 2004 | 119 | 0.060 |
Why?
| | Menthol | 1 | 2024 | 12 | 0.050 |
Why?
| | Membrane Potentials | 1 | 2004 | 284 | 0.050 |
Why?
| | Injections, Intraperitoneal | 2 | 2001 | 114 | 0.050 |
Why?
| | Mice, 129 Strain | 2 | 2015 | 88 | 0.050 |
Why?
| | Sequence Analysis | 1 | 2003 | 36 | 0.050 |
Why?
| | Tobacco Products | 2 | 2019 | 138 | 0.050 |
Why?
| | Threonine | 1 | 2003 | 47 | 0.050 |
Why?
| | Risk Factors | 5 | 2022 | 10388 | 0.050 |
Why?
| | Electroporation | 1 | 2003 | 38 | 0.050 |
Why?
| | Tobacco Smoking | 1 | 2023 | 25 | 0.050 |
Why?
| | Middle Aged | 9 | 2019 | 33479 | 0.050 |
Why?
| | Sequence Alignment | 1 | 2003 | 343 | 0.050 |
Why?
| | Alanine | 1 | 2003 | 152 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2003 | 179 | 0.050 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2022 | 16 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 125 | 0.050 |
Why?
| | Exons | 1 | 2003 | 355 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2003 | 390 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2010 | 3284 | 0.050 |
Why?
| | Synaptic Transmission | 1 | 2024 | 289 | 0.050 |
Why?
| | DNA | 3 | 2010 | 1459 | 0.050 |
Why?
| | Biological Transport, Active | 1 | 2001 | 77 | 0.050 |
Why?
| | Genetic Loci | 1 | 2022 | 288 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 840 | 0.040 |
Why?
| | Serum Albumin, Bovine | 1 | 2001 | 64 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2001 | 272 | 0.040 |
Why?
| | Adolescent | 7 | 2019 | 21513 | 0.040 |
Why?
| | Blotting, Western | 1 | 2003 | 1226 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 305 | 0.040 |
Why?
| | Interneurons | 1 | 2001 | 122 | 0.040 |
Why?
| | Injections, Intraventricular | 1 | 2000 | 55 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2004 | 2900 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 73 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1783 | 0.040 |
Why?
| | Odds Ratio | 2 | 2016 | 1070 | 0.040 |
Why?
| | Hybridization, Genetic | 1 | 2000 | 78 | 0.040 |
Why?
| | Hyperkinesis | 1 | 2019 | 16 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2005 | 654 | 0.040 |
Why?
| | Methylphenidate | 1 | 2019 | 38 | 0.040 |
Why?
| | Gene Transfer Techniques | 1 | 2000 | 170 | 0.040 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 57 | 0.040 |
Why?
| | Cattle | 1 | 2001 | 984 | 0.040 |
Why?
| | Protective Factors | 1 | 2018 | 93 | 0.040 |
Why?
| | Linkage Disequilibrium | 2 | 2009 | 268 | 0.040 |
Why?
| | Autophagosomes | 1 | 2017 | 19 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 1999 | 1272 | 0.030 |
Why?
| | Prepulse Inhibition | 1 | 2017 | 8 | 0.030 |
Why?
| | Protein Binding | 1 | 2003 | 2224 | 0.030 |
Why?
| | Inflammasomes | 1 | 2018 | 131 | 0.030 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2017 | 45 | 0.030 |
Why?
| | Kinetics | 4 | 2004 | 1670 | 0.030 |
Why?
| | Young Adult | 4 | 2016 | 13209 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3412 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1996 | 173 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 372 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 390 | 0.030 |
Why?
| | Binding Sites | 3 | 2007 | 1303 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2009 | 2526 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2017 | 125 | 0.030 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2015 | 55 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2018 | 513 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 284 | 0.030 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 413 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 385 | 0.030 |
Why?
| | DNA Primers | 2 | 2008 | 515 | 0.030 |
Why?
| | Transcription Factors | 1 | 2022 | 1719 | 0.030 |
Why?
| | Mice, Inbred AKR | 2 | 2003 | 35 | 0.030 |
Why?
| | Mice, Inbred A | 2 | 2003 | 49 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1040 | 0.030 |
Why?
| | NF-kappa B | 1 | 2017 | 691 | 0.030 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2013 | 86 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 967 | 0.020 |
Why?
| | Down-Regulation | 1 | 2015 | 657 | 0.020 |
Why?
| | Lactation | 1 | 2014 | 181 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 2008 | 1062 | 0.020 |
Why?
| | Adolescent Development | 1 | 2012 | 86 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3556 | 0.020 |
Why?
| | Aged | 3 | 2018 | 23961 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 7635 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1547 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2837 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4565 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4030 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 363 | 0.020 |
Why?
| | Respiration | 3 | 2002 | 199 | 0.020 |
Why?
| | Dizziness | 1 | 2010 | 82 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2014 | 561 | 0.020 |
Why?
| | Ligands | 2 | 2003 | 664 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2012 | 204 | 0.020 |
Why?
| | Receptors, Muscarinic | 1 | 1989 | 19 | 0.020 |
Why?
| | Heart Rate | 4 | 2002 | 822 | 0.020 |
Why?
| | Alkylation | 1 | 1988 | 26 | 0.020 |
Why?
| | Pharmacogenetics | 1 | 1989 | 180 | 0.020 |
Why?
| | Disulfides | 1 | 1988 | 107 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2008 | 329 | 0.020 |
Why?
| | Receptors, Opioid | 1 | 1987 | 25 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 129 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 391 | 0.020 |
Why?
| | Family Health | 1 | 2008 | 196 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 530 | 0.020 |
Why?
| | MicroRNAs | 1 | 2013 | 692 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 184 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7604 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1289 | 0.020 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 138 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1991 | 0.010 |
Why?
| | Logistic Models | 1 | 2010 | 2074 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2008 | 1509 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2828 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 1988 | 1060 | 0.010 |
Why?
| | Receptors, Neurotransmitter | 1 | 2003 | 18 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6079 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2004 | 534 | 0.010 |
Why?
| | Substantia Nigra | 1 | 2003 | 57 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2003 | 298 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 442 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 795 | 0.010 |
Why?
| | Drug Tolerance | 3 | 1987 | 105 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 665 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9465 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1353 | 0.010 |
Why?
| | Cell Count | 1 | 2001 | 324 | 0.010 |
Why?
| | Hypothermia | 1 | 2001 | 36 | 0.010 |
Why?
| | Veratridine | 1 | 2000 | 6 | 0.010 |
Why?
| | United States | 1 | 2018 | 14841 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2000 | 59 | 0.010 |
Why?
| | Drug Resistance | 1 | 2001 | 169 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11074 | 0.010 |
Why?
| | Potassium | 1 | 2000 | 147 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2001 | 204 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2001 | 347 | 0.010 |
Why?
| | Genetic Testing | 1 | 2001 | 460 | 0.010 |
Why?
| | Cohort Studies | 1 | 2009 | 5742 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2001 | 1738 | 0.010 |
Why?
| | Child | 1 | 2015 | 21935 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 10811 | 0.010 |
Why?
| | Quinuclidinyl Benzilate | 1 | 1989 | 2 | 0.000 |
Why?
| | Dithionitrobenzoic Acid | 1 | 1986 | 3 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1986 | 362 | 0.000 |
Why?
| | Infusions, Intravenous | 1 | 1987 | 413 | 0.000 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 111 | 0.000 |
Why?
| | Hot Temperature | 1 | 1986 | 391 | 0.000 |
Why?
| | Oxygen Consumption | 1 | 1986 | 696 | 0.000 |
Why?
|
|
Stitzel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|